<html xmlns:v="urn:schemas-microsoft-com:vml" xmlns:o="urn:schemas-microsoft-com:office:office" xmlns:w="urn:schemas-microsoft-com:office:word" xmlns:m="http://schemas.microsoft.com/office/2004/12/omml" xmlns="http://www.w3.org/TR/REC-html40"><head><meta http-equiv=Content-Type content="text/html; charset=us-ascii"><meta name=Generator content="Microsoft Word 14 (filtered medium)"><style><!--
/* Font Definitions */
@font-face
        {font-family:Calibri;
        panose-1:2 15 5 2 2 2 4 3 2 4;}
@font-face
        {font-family:Tahoma;
        panose-1:2 11 6 4 3 5 4 4 2 4;}
@font-face
        {font-family:"Trebuchet MS";
        panose-1:2 11 6 3 2 2 2 2 2 4;}
/* Style Definitions */
p.MsoNormal, li.MsoNormal, div.MsoNormal
        {margin:0cm;
        margin-bottom:.0001pt;
        font-size:11.0pt;
        font-family:"Calibri","sans-serif";
        mso-fareast-language:EN-US;}
a:link, span.MsoHyperlink
        {mso-style-priority:99;
        color:blue;
        text-decoration:underline;}
a:visited, span.MsoHyperlinkFollowed
        {mso-style-priority:99;
        color:purple;
        text-decoration:underline;}
p.MsoPlainText, li.MsoPlainText, div.MsoPlainText
        {mso-style-priority:99;
        mso-style-link:"Plain Text Char";
        margin:0cm;
        margin-bottom:.0001pt;
        font-size:11.0pt;
        font-family:"Calibri","sans-serif";
        mso-fareast-language:EN-US;}
p.MsoAcetate, li.MsoAcetate, div.MsoAcetate
        {mso-style-priority:99;
        mso-style-link:"Balloon Text Char";
        margin:0cm;
        margin-bottom:.0001pt;
        font-size:8.0pt;
        font-family:"Tahoma","sans-serif";
        mso-fareast-language:EN-US;}
span.EmailStyle17
        {mso-style-type:personal-compose;
        font-family:"Calibri","sans-serif";
        color:windowtext;}
span.BalloonTextChar
        {mso-style-name:"Balloon Text Char";
        mso-style-priority:99;
        mso-style-link:"Balloon Text";
        font-family:"Tahoma","sans-serif";}
span.PlainTextChar
        {mso-style-name:"Plain Text Char";
        mso-style-priority:99;
        mso-style-link:"Plain Text";
        font-family:"Calibri","sans-serif";}
.MsoChpDefault
        {mso-style-type:export-only;
        mso-fareast-language:EN-US;}
@page WordSection1
        {size:612.0pt 792.0pt;
        margin:72.0pt 72.0pt 72.0pt 72.0pt;}
div.WordSection1
        {page:WordSection1;}
/* List Definitions */
@list l0
        {mso-list-id:1479953638;
        mso-list-type:hybrid;
        mso-list-template-ids:-278335968 134807567 134807577 134807579 134807567 134807577 134807579 134807567 134807577 134807579;}
@list l0:level1
        {mso-level-tab-stop:none;
        mso-level-number-position:left;
        text-indent:-18.0pt;}
@list l0:level2
        {mso-level-number-format:alpha-lower;
        mso-level-tab-stop:none;
        mso-level-number-position:left;
        text-indent:-18.0pt;}
@list l0:level3
        {mso-level-number-format:roman-lower;
        mso-level-tab-stop:none;
        mso-level-number-position:right;
        text-indent:-9.0pt;}
@list l0:level4
        {mso-level-tab-stop:none;
        mso-level-number-position:left;
        text-indent:-18.0pt;}
@list l0:level5
        {mso-level-number-format:alpha-lower;
        mso-level-tab-stop:none;
        mso-level-number-position:left;
        text-indent:-18.0pt;}
@list l0:level6
        {mso-level-number-format:roman-lower;
        mso-level-tab-stop:none;
        mso-level-number-position:right;
        text-indent:-9.0pt;}
@list l0:level7
        {mso-level-tab-stop:none;
        mso-level-number-position:left;
        text-indent:-18.0pt;}
@list l0:level8
        {mso-level-number-format:alpha-lower;
        mso-level-tab-stop:none;
        mso-level-number-position:left;
        text-indent:-18.0pt;}
@list l0:level9
        {mso-level-number-format:roman-lower;
        mso-level-tab-stop:none;
        mso-level-number-position:right;
        text-indent:-9.0pt;}
ol
        {margin-bottom:0cm;}
ul
        {margin-bottom:0cm;}
--></style><!--[if gte mso 9]><xml>
<o:shapedefaults v:ext="edit" spidmax="1026" />
</xml><![endif]--><!--[if gte mso 9]><xml>
<o:shapelayout v:ext="edit">
<o:idmap v:ext="edit" data="1" />
</o:shapelayout></xml><![endif]--></head><body lang=EN-GB link=blue vlink=purple><div class=WordSection1><p class=MsoPlainText><span style='font-family:"Trebuchet MS","sans-serif";color:black'>Why is the NIH proving more successful in achieving compliance with its open access policy than the Wellcome Trust (which currently has a compliance rate of 55%).<o:p></o:p></span></p><p class=MsoPlainText><span style='font-family:"Trebuchet MS","sans-serif";color:black'><o:p> </o:p></span></p><p class=MsoPlainText><span style='font-family:"Trebuchet MS","sans-serif";color:black'>- The initial NIH voluntary policy saw compliance rates of 19%.</span><br><br><span style='font-family:"Trebuchet MS","sans-serif";color:black'>-The mandatory policy (introduced in April 2008) saw compliance grow to 49% by the end of 2008, 70% by the end of 2009 and currently stands at 75%.</span><br><br><span style='font-family:"Trebuchet MS","sans-serif";color:black'>-In order to increase compliance the NIH has a) engaged in awareness programs; b) improved its ability to track papers resulting from NIH research awards; c) developed new systems to assist sponsored research offices at universities and medical research centres in tracking their compliance; d) improved the submission process for authors by i) co-opting publishers to deposit for authors and ii) introducing the <a href="http://www.nihms.nih.gov/">NIH Manuscript Submission System</a>.<o:p></o:p></span></p><p class=MsoPlainText style='margin-left:36.0pt'><span style='font-family:"Trebuchet MS","sans-serif";color:black'><o:p> </o:p></span></p><p class=MsoPlainText><span style='font-family:"Trebuchet MS","sans-serif";color:black'>One noteworthy point is that, while the NIH clearly takes a close interest in compliance levels, it does not collect statistics on enforcement actions. With the growth in compliance now apparently levelling off at NIH, this would surely be useful information — and not just for NIH itself, but also for other funders like the Wellcome Trust and Research Councils UK (<a href="http://www.rcuk.ac.uk/Pages/Home.aspx">RCUK</a>), both of whom are currently looking to <a href="http://www.openscholarship.org/jcms/c_7297/new-stronger-uk-research-councils-policy-on-open-access">beef up</a> their open access policies.</span><o:p></o:p></p><p class=MsoPlainText><o:p> </o:p></p><p class=MsoPlainText><a href="http://poynder.blogspot.co.uk/2012/05/open-access-mandates-ensuring.html">http://poynder.blogspot.co.uk/2012/05/open-access-mandates-ensuring.html</a><o:p></o:p></p><p class=MsoNormal><o:p> </o:p></p><p class=MsoNormal><o:p> </o:p></p><p class=MsoNormal><o:p> </o:p></p></div></body></html>